Kuliah Prof Delfi

Embed Size (px)

Citation preview

  • 8/6/2019 Kuliah Prof Delfi

    1/26

    WHO Spesial Programme Reseach Development and

    Research Training in Human Reproduction

    Preparing a Research

    Project Proposal

    Guidelines and FormsWorld Health Organization

    Geneva.

  • 8/6/2019 Kuliah Prof Delfi

    2/26

    Rationale and Objectives

    Rationale- justify the proposal

    - hypotheses to be testes- endpoints

    - justify use of human subjects

    Objectives- main

    - subsidiary

  • 8/6/2019 Kuliah Prof Delfi

    3/26

    Background

    Previous Similar Studies

  • 8/6/2019 Kuliah Prof Delfi

    4/26

    Design and Methodology

    General Outline

    Criteria for subject selection

    Subject allocation

    Description of drugs and/or devices to be

    studied

    Admission procedure

    Follow-up procedure

    Criteria for discontinuation

  • 8/6/2019 Kuliah Prof Delfi

    5/26

    Design and Methodology cont

    Laboratory and other investigations

    Data management

    Data analysis

    Sample size

    D

    uration of project

  • 8/6/2019 Kuliah Prof Delfi

    6/26

    Subject Allocation

    Type

    Method

    Where allocation will take place

    Access to hospital/clinic records

  • 8/6/2019 Kuliah Prof Delfi

    7/26

    Description ofDrug/Device

    Commercially available

    New drugs/devices/vehicles

    - toxicology

    - pharmacology

    - bioavailability

    - human studies

  • 8/6/2019 Kuliah Prof Delfi

    8/26

    Criteria for subject Selection

    Describe and justify the population

    chosen for the study

    Inclusion criteria

    Exclusion criteria

  • 8/6/2019 Kuliah Prof Delfi

    9/26

    Criteria for Subject Selection cont

    Selection of comparison groups andmatching criteria

    Sampling procedures and type of sample

    How will potential subjects beapproached and recruited?

    Access to hospital/clinic records

  • 8/6/2019 Kuliah Prof Delfi

    10/26

    Admission Procedure

    Timing of subject interview

    Allocation to study groups

    Data to be recorded upon admission

    Information on subjects declining to

    participate

  • 8/6/2019 Kuliah Prof Delfi

    11/26

    Follow-up Procedure

    Frequency and timing of follow-up

    Investigations to be conducted

    Data to be collected

    Subject tracing

  • 8/6/2019 Kuliah Prof Delfi

    12/26

    Discontinuation Criteria

    Subject discontinuation

    Treatment discontinuation

    Study discontinuation

  • 8/6/2019 Kuliah Prof Delfi

    13/26

    Sample Size and Statistical Power

    Estimate incidence and prevalence rates

    Differences this study is expected to detect

    Power required to demonstrate these difference

    Method of computation of sample size

    Variablities to be expected

  • 8/6/2019 Kuliah Prof Delfi

    14/26

    Data Management and Analysis

    Data coding, monitoring and verification

    Administrative/computer procedures to beused

    Staff available

    Statistical methods to be used to testhypothesis

  • 8/6/2019 Kuliah Prof Delfi

    15/26

    Data Management and Analysis

    contt Loss to follow-up, subject discontinuation

    Subgroup analyses/comparisons

    Special statistical techniques

    Qualitive approaches

  • 8/6/2019 Kuliah Prof Delfi

    16/26

    Laboratory/Other Investigations

    Diagnostic and investigative procedures

    Essential tests and new tests

    Routine tests

  • 8/6/2019 Kuliah Prof Delfi

    17/26

    Duration of Project

    Time needed to recruit subjects

    Collection of samples/specimens

    Follow-up

    Laboratory tests

    Data analysis

    Report/manuscript writing

  • 8/6/2019 Kuliah Prof Delfi

    18/26

    Ethical Considerations

    Declaration of Helsinki

    International Principles forBiomedicalResearch involving animals (CIOMS)

    Local institutional ethics committee

    National ethics committee

  • 8/6/2019 Kuliah Prof Delfi

    19/26

    Informed Consent (A)

    Detailed descriptin of the research

    In language subject can understand

    Details of any benefits or compensation and

    when it will be given

    Details of discomfort, side effects, risks

    anticipated

    Comparison with available standard drugs or

    treatments

  • 8/6/2019 Kuliah Prof Delfi

    20/26

    Informed Consent (B)

    All information given by the subject and all

    laboratory data are confidential

    State to whom the subjects data will be

    disclosed

    Subject free to withdraw from the research

    without prejudice to current or future

    treatment

  • 8/6/2019 Kuliah Prof Delfi

    21/26

    Informed Consent (C)

    SPECIAL CASES

    Illiterate cases

    Commercial sexworkers Children/adolescents

    Institutionalized (prisoners, armed services)

    Emotionally disturbed Mentally handicapped

  • 8/6/2019 Kuliah Prof Delfi

    22/26

    Ethical Review

    SHOULDBE BASED UPON:

    Helsinki declaration

    International ethical guidelines for biomedicalresearch involving human subjects

    International guidelines for ethical review of

    epidemiological studies International guiding principles for biomedical

    research involving animals

  • 8/6/2019 Kuliah Prof Delfi

    23/26

    Ethical Considerations

    Declaration of helsinki

    Interanational principles for biomedicalresearch involving animals (CIOMS)

    Local institutional ethics committee

    National ethics committe

  • 8/6/2019 Kuliah Prof Delfi

    24/26

    Sample Bar Chart

    ACTIVIYT Year 1 Year 2 Year 3

    Recruitment ------------------------------------

    Sample collection-------------------Follow-up -------------------------------

    Laboratory tests--------------------

    Data Analys interim finalManuscript --------

  • 8/6/2019 Kuliah Prof Delfi

    25/26

    Project Summary

    Justification for the project

    Summary of proposed research

    New features

    Techniques and skills required

    Problems anticipated

  • 8/6/2019 Kuliah Prof Delfi

    26/26

    PROJECT CLEARANCE PATHWAYPROJECT CLEARANCE PATHWAY

    Institues reviewcommittee(s)

    Task Force Steering

    Committee, WHO

    Scientific and Eyhical

    Review Group, WHO

    Secreatariat Committee on

    Research Involving Human

    Subjects (SCRIHS)

    Toxicology

    Panel

    Investigator

    WHO Secretariat

    National/

    government

    clearance

    Funding